abstract |
THE PRESENT INVENTION REFERS TO PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A LIPASE INHIBITOR, PREFERIBLY ORLISTAT AND GLUCOMANAN FOR WHICH THEY ARE USEFUL FOR THE TREATMENT OF OBESITY. THE COMPOSITION PREVENTS INDEXABLE GASTROINTESTINAL SECONDARY EFFECTS SUCH AS OIL SPOT, FATTY / OILY VOLUMETRIC MASSES, FECAL URGENCY. |